China Universal Asset Management Company’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,076
| Closed | -$3.33K | – | 472 |
|
|
2023
Q3 | $3.33K | Buy |
1,076
+389
| +57% | +$1.2K | ﹤0.01% | 411 |
|
|
2023
Q2 | $3.09K | Buy |
687
+38
| +6% | +$171 | ﹤0.01% | 406 |
|
|
2023
Q1 | $3.7K | Buy |
649
+279
| +75% | +$1.59K | ﹤0.01% | 396 |
|
|
2022
Q4 | $2.24K | Sell |
370
-78
| -17% | -$471 | ﹤0.01% | 364 |
|
|
2022
Q3 | $3K | Buy |
+448
| New | +$3K | ﹤0.01% | 332 |
|